Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction.

[1]  A. Evans,et al.  Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations , 1999, Genetic epidemiology.

[2]  D. Wilcken,et al.  Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population. , 1999, Atherosclerosis.

[3]  W. Willett,et al.  A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  Y. Yazaki,et al.  Polymorphism of the methionine synthase gene : association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[5]  G. Cranney,et al.  The Frequency of a Common Mutation of the Methionine Synthase Gene in the Australian Population and its Relation to Smoking and Coronary Artery Disease , 1998, Journal of cardiovascular risk.

[6]  J. Manson,et al.  Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.

[7]  H. Blom,et al.  Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. , 1997, QJM : monthly journal of the Association of Physicians.

[8]  B. Shane,et al.  Human Methionine Synthase , 1997, The Journal of Biological Chemistry.

[9]  P. Goyette,et al.  Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. , 1996, Human molecular genetics.

[10]  R. Banerjee,et al.  Cloning, mapping and RNA analysis of the human methionine synthase gene. , 1996, Human molecular genetics.

[11]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[12]  W. Willett,et al.  A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. , 1996, Journal of the American College of Nutrition.

[13]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[14]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[15]  T. Tamura,et al.  Inhibition of EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. , 1990, Clinical chemistry.

[16]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[17]  R. Matthews,et al.  Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology , 1998, European Journal of Pediatrics.

[18]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[19]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.